Skip to content

Type: Congressional Briefing

Senate Briefing – Turning the Tables: Innovator Meets Regulator

Friends of Cancer Research Senate Briefing – Turning the Tables: Innovator Meets Regulator A Dialogue with Stakeholders & FDA on Keeping Pace with Innovation & Patient Needs Dirksen Senate Office Building ​Room 430​Washington​, ​DC ​20002 Tuesday, December 10, 2019 12:00 PM EST – 1:00 PM EST Lunch will be provided. Register Today! Speakers: Dr. Josh…

Safeguarding the Public Health: Enhancing Information About Prescription Drugs

To access a recap of this past event, please Click HERE. Friends of Cancer Research Congressional Briefing Safeguarding the Public Health: Enhancing Information About Prescription Drugs Hart Senate Office Building ​Room 216 ​Washington​, ​DC, ​20002 Tuesday, March 20, 2018 2:00 PM – 3:30 PM EDT Patients, caregivers and their physicians and nurses need high quality…

The Cancer Moonshot Initiative: Current and Future Cancer Research Objectives

Please join the National Coalition for Cancer Research and the American Association for Cancer Research for our upcoming “Cancer 101” Congressional Briefing Series event: The Cancer Moonshot Initiative: Current and Future Cancer Research Objectives Monday, March 20, 2017 12:00 -1:30 pm 2045 Rayburn House Office Building (formerly B-340) Register at msmith@libertypartnersgroup.com Lunch will be served…

Senate HELP Committee Hearing – “Laboratory Testing in the Era of Precision Medicine”

On September 20th, 2016, the Senate Health, Education, Labor and Pensions Committee convened a hearing to discuss laboratory testing the in the era of precision medicine. The hearing took place amid an ongoing debate over the proper regulatory framework for laboratory-developed tests (LDTs). LDTs are in vitro diagnostic tests (IVDs) that are made and performed…

Friends of Cancer Research Senate Briefing: The Future of Precision Medicine & Patient Care

Senate Briefing The Future of Precision Medicine & Patient Care: Current Landscape in Genomic Testing Thursday, October 13th, 2016 – 12:00pm-1:00pm 430 Dirksen Senate Office Building Washington, DC On Thursday, October 13th, 2016, Friends of Cancer Research and the Deerfield Institute convened a briefing on Capitol Hill to discuss current and future regulatory issues related…

National Coalition for Cancer Research & One Voice Against Cancer: Briefing on the National Cancer Moonshot

           Please join the National Coalition for Cancer Research & One Voice Against Cancer for a Lunch briefing and Panel Discussion regarding the National Cancer Moonshot Blue Ribbon Panel Report Special Guest Speaker: Douglas R. Lowy, M.D. Acting Director National Cancer Institute Tuesday, September 27 from 12:00 – 1:30 pm EDT…

National Coalition for Cancer Research Briefing – The Cancer “Moonshot” Initiative: New Frontiers in Cancer Exploration

Please join the National Coalition for Cancer Research for their upcoming “Cancer 101” Congressional Briefing Series event: The Cancer “Moonshot” Initiative: New Frontiers in Cancer Exploration Monday, April 25, 2016 12:00 – 1:30 pm 485 Russell Senate Office Building RSVP at nccrcoalition@gmail.com Lunch will be served at this widely-attended event. President Obama has issued a…

Friends of Cancer Research Senate Briefing: Breakthrough Therapy Designation

Breakthrough Therapy Designation: Successes, Lessons Learned and Future Strategies Tuesday, April 12, 2016 – 12:30pm-2:00pm Capitol Visitor’s Center, Room SVC 212-10 Washington, DC 20515 A Friends of Cancer Research Senate Briefing on the FDA’s breakthrough therapy designation Limited space is available. Register Now! Opening Keynote by Senator Michael Bennet (D-CO) Panelists: Janet Woodcock, Director, Center…

Centers of Excellence at the FDA: A Disease-Oriented Approach to Medical Product Development

Centers of Excellence at the FDA:  A Disease-Oriented Approach to Medical Product Development A Friends of Cancer Research (Friends) Senate Briefing on Opportunities for Cross-Center Coordination at the FDA to Reflect Current Patient Care February 24, 2016 – 11:00am-12:00pm US Capitol Visitors Center, SVC201-00 – Washington, DC Event Summary: Congress has not modernized FDA’s organizational structure for medical…

Science and Progress at the FDA: A Friends of Cancer Research Congressional Briefing on the Progress of the FDA’s Breakthrough Therapies Program

On May 6th,  Friends of Cancer Research (Friends) hosted a congressional briefing entitled, “Science and Progress at the FDA: A Friends of Cancer Research Congressional Briefing on the Progress of the FDA’s Breakthrough Therapy Program.” The event was sponsored by Senators Michael Bennet (D-CO), Orrin Hatch (R-UT), and Richard Burr (R-NC), who together introduced the initial legislative…